Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypothermic Oxygenated Perfusion (HOPE) Against Cancer Recurrence in HCC Liver Transplantation - International Multicentre Parallel Group Interventional RCT

NCT06717919 is registered in ClinicalTrials.gov with Philipp Dutkowski as lead sponsor.

NCT NCT06717919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06717919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypothermic Oxygenated Perfusion (HOPE) Against Cancer Recurrence in HCC Liver Transplantation - International Multicentre Parallel Group Interventional RCT
Lead sponsor
Philipp Dutkowski
Phase
Phase 4
Overall status
Recruiting
Start date
August 1, 2025
Completion date
January 31, 2028
Enrollment
220 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

hcc, liver transplantation, oncological outcomes